U.S. Markets close in 1 hr 11 mins

What Are Analysts Recommending for NBIX after Q1 Results?

Margaret Patrick
What Are Analysts Recommending for NBIX after Q1 Results?

Is Neurocrine Biosciences an Attractive Pick after Q1 Results?Stock price movementsNeurocrine Biosciences (NBIX) reported first-quarter results on April 29. The company reported total revenues of $138.40 million, a YoY rise of 94.70%. Posted